Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Lymphangiomyoma × Octreotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Zollinger-Ellison Syndrome 1 Vipoma 1 Somatostatinoma 1 Recurrence 1 Pleural Effusion 1 Paraganglioma 1 Neuroendocrine Tumors 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Merkel Cell 1 Carcinoma, Medullary 1 Ascites 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00005906 2010-04-30

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

4 enrolled 8 charts

Ascites, Chylous Ascites, Chylothorax, Lymphangiomyoma, Pleural Effusion, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡